50
Participants
Start Date
November 17, 2010
Primary Completion Date
January 23, 2012
Study Completion Date
January 23, 2012
bleselumab
Intravenous (IV) infusion
Placebo
Intravenous (IV) infusion
Central Pennsylvania Transplant Associates, Harrisburg
University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Emory University, Atlanta
Methodist University Hospital, Memphis
Christ Hospital, Cincinnati
University of Cincinnati - University Internal Medicine Associates, Cincinnati
University of Michigan, Ann Arbor
University of Wisconsin, Madison
Loyola University Medical Center, Maywood
University of Illinois Medical Center, Chicago
Baylor University Medical Center, Dallas
The Methodist Hospital, Houston
University of Colorado Denver, Aurora
University of Utah Hospital, Salt Lake City
California Institute of Renal Research, San Diego
California Pacific Medical Center, San Francisco
UCSF Medical Center, San Francisco
Stanford University Medical Center, Palo Alto
Beth Israel Deaconess Medical Center, The Transplant Institute, Boston
St. Barnabas Medical Center, Livingston
Lead Sponsor
Kyowa Kirin Co., Ltd.
INDUSTRY
Astellas Pharma Inc
INDUSTRY